1. Home
  2. CPK vs DNLI Comparison

CPK vs DNLI Comparison

Compare CPK & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPK
  • DNLI
  • Stock Information
  • Founded
  • CPK 1990
  • DNLI 2013
  • Country
  • CPK United States
  • DNLI United States
  • Employees
  • CPK N/A
  • DNLI N/A
  • Industry
  • CPK Oil & Gas Production
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CPK Utilities
  • DNLI Health Care
  • Exchange
  • CPK Nasdaq
  • DNLI Nasdaq
  • Market Cap
  • CPK 2.9B
  • DNLI 2.4B
  • IPO Year
  • CPK N/A
  • DNLI 2017
  • Fundamental
  • Price
  • CPK $131.83
  • DNLI $15.92
  • Analyst Decision
  • CPK Hold
  • DNLI Strong Buy
  • Analyst Count
  • CPK 2
  • DNLI 14
  • Target Price
  • CPK $128.50
  • DNLI $33.50
  • AVG Volume (30 Days)
  • CPK 143.9K
  • DNLI 1.7M
  • Earning Date
  • CPK 11-06-2025
  • DNLI 11-10-2025
  • Dividend Yield
  • CPK 2.08%
  • DNLI N/A
  • EPS Growth
  • CPK 16.73
  • DNLI N/A
  • EPS
  • CPK 5.60
  • DNLI N/A
  • Revenue
  • CPK $866,700,000.00
  • DNLI N/A
  • Revenue This Year
  • CPK $13.36
  • DNLI N/A
  • Revenue Next Year
  • CPK $6.09
  • DNLI $94,232.03
  • P/E Ratio
  • CPK $23.53
  • DNLI N/A
  • Revenue Growth
  • CPK 18.91
  • DNLI N/A
  • 52 Week Low
  • CPK $115.12
  • DNLI $10.57
  • 52 Week High
  • CPK $140.59
  • DNLI $33.33
  • Technical
  • Relative Strength Index (RSI)
  • CPK 48.27
  • DNLI 55.01
  • Support Level
  • CPK $128.99
  • DNLI $15.53
  • Resistance Level
  • CPK $135.03
  • DNLI $17.72
  • Average True Range (ATR)
  • CPK 2.76
  • DNLI 0.90
  • MACD
  • CPK -0.94
  • DNLI 0.01
  • Stochastic Oscillator
  • CPK 24.44
  • DNLI 53.51

About CPK Chesapeake Utilities Corporation

Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by PSC. Eastern Shore, its natural gas transmission is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Share on Social Networks: